BioMarin (United Kingdom)
BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research are in enzyme replacement therapies. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for BioMarin (United Kingdom), United Kingdom, covering academic research published from 2010 to 2024. Read More.
Open Access Percentage
74%
Total
Publications
106
Total Open
Publications
78
Total
Citations
2.3K
Open Access
Percentage
74%
Total
Publications
106
Total Open
Publications
78
Total
Citations
2.3K
Breakdown
Publisher Open
28%
Both
43%
Other Platform Open
1%
Closed
28%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 56%
41
Hybrid 32%
23
No Guarantees 12%
9
Other Platform Open
Domain 83%
40
Institution 33%
16
Other Internet 15%
7
Public 2%
1
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 39 |
Royal Netherlands Academy of Arts and Sciences | Institution | 6 |
DOI | Other Internet | 5 |
King's College London | Institution | 4 |
University of Melbourne | Institution | 3 |
Europe PMC | Domain | 3 |
Unknown Repository | Other Internet | 2 |
University of Buenos Aires | Institution | 2 |
aecid.es OAI-PMH Repository | Institution | 2 |
ZB MED - Information Centre for Life Sciences | Institution | 1 |